Complex of human recombinant PRMT and MEP50 proteins. Recombinant human PRMT5 (protein arginine methyltransferase 5, variant 1), encompassing amino acids 2-637(end). This construct contains an N-terminal Flag-tag. Recombinant human MEP50 (WD repeat domain 77, variant 2), encompassing amino acids 2-342(end). This construct contains an N-terminal His-tag (6xHis). The two proteins were co-expressed and affinity purified.
Three types of arginine methylation exist in mammalian cells: monomethylarginine (MMA), asymmetric dimethylarginine (ADMA) and symmetric dimethylarginine (SDMA). Type I PRMTs ((CARM1, PRMT1, PRMT2, PRMT3, PRMT6, and PRMT8) catalyze ADMA, while type II PRMTs (e.g. PRMTs 5 and 7) catalyze SDMA. Type II PRMTs are found to be strongly implicated in diseases like cancer. For example, PRMT5 plays a role in the repression of certain tumor suppressor genes such as RB tumor suppressors while PRMT7 overexpression is observed in breast cancer
Storage/Stability
At least 6 months at -80°C.
Assay Conditions
Assay was performed according to the PRMT5 Chemiluminescent Assay Kit (BPS Bioscience #52002L) with PRMT5 enzyme titrated from 800 ng/rxn – 0.78 ng/rxn.
Instructions for Use
Thaw on ice and gently mix prior to use. DO NOT VORTEX. Perform a quick spin before opening. Aliquot into small volumes and flash freeze for long term storage. Avoid multiple freeze/thaw cycles.
Applications
Useful for the study of enzyme kinetics, screening inhibitors, and selectivity profiling.